Engineered Cell-Based Therapeutics: Synthetic Biology Meets Immunology

Synthetic Biology has enabled new approaches to several medical applications including the development of immunotherapies based on bioengineered cells, and most notably the engineering of T-cells with tumor-targeting receptors, the Chimeric Antigen Receptor (CAR)-T cells. CAR-T-cells have successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Caliendo, Fabio, Dukhinova, Marina, Siciliano, Velia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431652/
https://www.ncbi.nlm.nih.gov/pubmed/30937303
http://dx.doi.org/10.3389/fbioe.2019.00043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431652/
https://www.ncbi.nlm.nih.gov/pubmed/30937303
http://dx.doi.org/10.3389/fbioe.2019.00043

Ejemplares similares